---
$id: https://graph.org.ai/products/commodity/51281626
$type: Product
source: UNSPSC
code: "51281626"
title: "Tobramycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tobramycin

**UNSPSC Code**: 51281626
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic with the molecular formula C18H37N5O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VZ8RRZ51VK, chemically known as tobramycin, free base but generally known as tobramycin, which bears US NIH Compound Identifier 5496. European Medicines Agency schedules Tobramycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11134MIG. The term TOBRAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules tobramycin in its Anatomical Therapeutic Chemical (ATC) Classification. TOBRAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tobramycin under HS 29419000 and SITC 54139. As of Q4 2014, TOBRAMYCIN remains the US FDA Preferred Term for this commodity. Tobramycin bears US NLM identifiers UMLS ID C0040341 and NCI Concept Code C62082. SMILES: O(C1C(O)C(OC2OC(C(O)CC2N)CN)C(N)CC1N)C1OC(C(O)C(N)C1O)CO.

